Howard Horn, Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 14,930 shares at $52.76 ($788K) on 2024-10-10, disclosed to the SEC on 2024-10-11.
Open-market sale of $788k RARE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.76 | 7,465 | $394K | 50.0% |
| 2 | $52.76 | 7,465 | $394K | 50.0% |
| Total | $52.76 avg | 14,930 | $788K | 100% |
| Filing → |
| RARE | SELL | 2026-06-01 | $111K | — | Filing → |
| RARE | SELL | 2026-05-04 | $117K | — | Filing → |
| RARE | SELL | 2026-04-02 | $98K | — | Filing → |